Dear Yves, dear Yury,

following our conversation regarding key points we should develop step by step (business plan which

obviously is a must have basis of any project to focus joint energy) to make the project successful and

get the best results please find additional information which will enable the potential the project has:

first of all, it is great to know that the concept was changed in favor of the PLATFORM rather than a

single niche company ico (with no read of the second disruptive part I’ve mentioned in the first letter)!

it changes perspectives of the project dramatically. but there is a lack of understanding

WHAT this platform is about:

turn on your attention please! you can see a lot of icos and ico launch platforms have been

starting to form some kind of platforms to collect all the businesses which are targeted to

launch their own ico BUT these platforms lost out of their attention a big thing, a big advantage

of DECENTRALIZATION – crowd wisdom! there is no need to collect some kind of investment

board but provide EACH of your token holder with the right to vote OR TO PASS this right to

some specialist who will be paid a fee for his competency. thus you will collect professional

crowd which will create a huge wisdom power to make a right investments choice. it is about

efficiency of investments and its risks cut down. that is about attractiveness of the platform not

just as a board of projects/icos but a TOOL to make a right choice which is professionally

supported. and a tool which provides certain participants with a possibility to earn profits with

no investments in terms of finance but competency, which is a currency also! REPUTATION is

the capital (and it should have a mechanics to be collected and stored)! it is briefly speaking.

WHO are the participants (it is about TARGET AUDIENCE):

investors’ group:

1) let me start with filling in a HUUUUGE gap you’ve missed – it is direct users of biotech

developments: DOCTORS. they not only represent the demand part of the market,

which put a certain drug in a recipe or use a certain device with a motivation to provide

patients with more successful result of treatment (which means they become more

powerful and SUCCESSFUL… in financial terms too) but do understand the direction the

market should move to. they are professionals. they are well WELL paid thus have a

huge investments potential and they will do invest as soon as they know the subject for

sure. that is about risk cutting factor for this group. please find more rationale regarding

this group below (“infrastructure group”),

2) regular non-institutional risk investors, who ARE NOT obligatory should be aware of

blockchain (for sure there should be a cutting edge support service to follow our clients

in the way of crypto-assets acquiring); moreover – the recommendation is to quit a

stupid ico rush and to have ico platforms and media as a second/third row in marketing

activity (BTW it will cut marketing budgets dramatically which go crazy month by month

and grow in geometric progression); it is about a correct focus in terms of target

audience and… the answer who is the ANCHOR group, who are specialists which will

attract non-professionals (which was mentioned above)! …it is about patients too.

and it is a crucially important to use appropriate message – you are the partner, we

create easy to enter the market tool, we are social active (it was put in a place as a good

advice to follow) etc. – to this part of the audience which was put in my previous note!

a little raw but still an idea: there should be developed consultancy strata among non-

investing users of the platform, which could buy some initial “karma” to start their

voting activity and collect some group of believers due to successful investment

analytics and good ROI – it is about creating portfolio managers… with THEIR OWN

INTRAPLATFORM TOKEN (pamm account analogy).

3) institutional investors – there are just several comments: (a) the proposition is to avoid

mentioning pension funds – it is too risky area for them and it creates impression that

we put each and everyone in the row of our clients which is not a professional attitude

(a little subjective but still); (b) please take it as a recommendation only despite the

second mentioning the team of ICOBox (which BTW took an active part in Money2020

which took place in London recently): the proposition is to have them as one of

distribution partners ico/pre-ico as soon as they have a wide network of agents within

US market among trusts, family funds etc. – they will be useful and seems to be ready to

work on a fee-basis only (will provide you with a direct telegram contact its CEO Mike

Raitsyn if you approve the decision).

infrastructure group:

please write the list of all possible participants of the process to create and launch a new drug or

technology – this is about investor side also BUT through service or material participation. there

should be some fee or minimum investments requirement to get access to a certain pool of

projects in terms of the stage and internal supply needs. and doctors we’ve mentioned above as

a TA – they get a cool access to a base of inside info regarding different drugs’ tests on different

stages (it is about providing the base to launch such test on a payment or investment basis AND

it is about concentrated base of cutting edge developments within the industry).

it is briefly speaking too.

HOW does it operate:

to answer the question there should be put in a list the whole range of ACTIVITIES which will

take place within the platform. it will help to answer the MAIN investors’ question where the

profits will come from – finance model should be structured.

appropriate TOOLS should be described in accordance to each type of activity and how these

tools are used. please find some assumptions as soon as there is a lack of information regarding

the product you are going to develop.

activity tool purpose

1 invest into the platform main/platform token = ATS fixes a share within the company and gets profits from e.g. as from (a) investments of core platform’s pros team, which acts as portfolio manager, as from (b) fees, which are collected from participants in accordance with the type of their activity (see below)

2 invest/issue or into/for (a) the company (b) portfolio manager (c) sector index “X”

derivative ATS-token with index = ATS-X (or just X) tradable ONLY within the platform)

fixes a share within a certain asset

3 get/provide credit company credit token – intra-cash

collect crediting to pay for services, materials (with some extra margin) to develop the project with no equity sharing

4 get additional services, possibilities within the platform or to get payment for extra-services e.g. investment analytics/advices form consultancy strata

ATScoin to get information regarding products in development, to vote for projects (developing internal analytic-rate), to get access to internal tenders base etc.

please be advised that there is no possibility to use a single token for numbers of functions.

a clear scheme of participants interaction and business processes whole map should be

developed and visualized to avoid misunderstanding from investors’ side (and our own too).

a clear scheme of tokens’ issue and its functions should be developed and put into all materials.

there should be put two examples by the end of this note:

1) http://backfeed.cc/ – VERY IMPORTANT ONE – it is about DECENTRALIZATION, which

should be put into the basis of the platform to develop; otherwise there gonna be

nothing to propose to the market which is eager to get a new wave organizations;

please pay attention to economic model, which will help you to form ATS-platform in

more EFFECTIVE way; and what is great – it is open source! just take the code and use it!

2) https://dogezer.com – the team which has passed successfully its pre-ico already having

a great product –“Platform that allows team members to become product investors by

investing their time and labor”; it will be useful in terms of point #3 of the table above –

please pay attention to the mechanics which is used to pay to each member of the

company.

And last but not least – compliance. As regarding the platform itself, as regarding the companies which

are going to collect funds through the platform. It is a big issue and a big pain of potential investor HOW

the deal will be structured in both cases. E.g. in case of Dogezer its CEO told me that the platform…

will have minority share within each project – it is about not only token further monetization, but a tool

to go to the court in case of any unfair activity from the company, which got fundraising through the

platform. and this leads us to an issue – each ico should be based on a new company launch within a

real life part to make it possible to structure the deal in an appropriate way. it is about guarantees which

almost nobody cares in crazy ico rush because of target audience mostly. but it is a matter of time. and

I am sure – the target audience of Aeternis project is much more risk sensitive, reputable and choosy.

so lets create new standards!